BD GENERICS ApS: Financial statements 2025
CVR: 28707207
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280. The solvency ratio was 62.6%.
- Revenue
- DKK 0
- Gross Profit
- DKK -117,586
- Profit/Loss
- DKK -64,678
- Equity
- DKK 638,280
- Total Assets
- DKK 1,019,928
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -118 t. | -65 t. | 638 t. | - |
| 2024 | 0 | -111 t. | -61 t. | 703 t. | - |
| 2023 | 0 | -101 t. | -64 t. | 764 t. | - |
| 2022 | 0 | -70 t. | -44 t. | 828 t. | - |
| 2021 | 0 | -7 t. | -13 t. | 872 t. | - |
Official annual report
How creditworthy is BD GENERICS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BD GENERICS ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -61,196.
About BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.